Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yasmin versus cyproterone compound in women with polycystic ovary syndrome and hirsutism
IRCT201104251760N13Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of drospirenone and cyproterone in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Babol University of Medical Sciences. Primary endpoints: Hirsutism change and Androgen level change. Started Feb 2012; status: completed.
02
Drugs
drospirenonecyproterone
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on IRCT201104251760N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201104251760N13.